Clik here to view.
Innovation & investment needed in drug delivery tech
When Menashe Levy was working on his Ph.D. from the Hebrew University of Jerusalem in the mid-80s, he encountered the very first renderings of innovation in drug delivery: controlled, sustained release...
View ArticleClik here to view.
CivaTech wins $2.3m NIH grant for CivaSheet study
CivaTech Oncology Inc. said this week that it landed a $2.3 million award from the National Institutes of Health to study pancreatic cancer with its CivaSheet device. The Durham, North Carolina-based...
View ArticleClik here to view.
Spirox touts 1-year results from Latera study
Spirox on Monday released 1-year results from a multi-center study of its Latera absorbable nasal implant, touting a significant reduction in nasal obstruction symptoms in patients with nasal valve...
View ArticleClik here to view.
Evaluating FDA’s approach to cancer clinical trials
By: Richard Pazdur, M.D. Since the announcement of the FDA Oncology Center of Excellence (OCE) two months ago (June 29, 2016) as part of the White House’s Cancer Moonshot, we’ve been working to further...
View ArticleClik here to view.
Global Kinetics wins FDA nod for 2nd-gen wearable kinetigraph
Global Kinetics Corp said today it won FDA 510(k) clearance for its next-gen wrist-worn personal kinetigraph system. The device is designed to record movement symptoms of Parkinson’s and provides...
View ArticleClik here to view.
BD invests $100m in Nebraska manufacturing plant expansion
Becton Dickinson & Co. (NYSE:BDX) said today it is investing $100 into expanding its Holdrege, Neb.-based facility to make extra room for insulin syringe manufacturing operations. The investment...
View ArticleClik here to view.
Report: Big data, AI hold “greatest promise” for healthcare tech
Big data and artificial intelligence will have the greatest impact in the health-tech industry in the year ahead, according to a survey released yesterday. The survey, performed by Silicon Valley Bank,...
View ArticleClik here to view.
Mylan CEO testifies before Senate about EpiPen pricing
Mylan CEO Heather Bresch testified before Senate yesterday after the Oversight and Government Reform Committee expressed concerns about the company’s price increases of its epinephrine auto-injector....
View ArticleClik here to view.
Cook Medical launches Zilver PTX thumbwheel in France
Cook Medical said today it won reimbursement from the French Health ministry for its Zilver PTX drug-eluting peripheral stent thumbwheel delivery system and launched the device in the country. The...
View ArticleClik here to view.
LivaNova launches next-gen ICD, CRT-Ds in US
LivaNova (NSDQ:LIVN) said today it is launching its next-gen Platinium implantable cardiac defibrillators and cardiac resynchronization therapy devices in the U.S. The next-gen devices include improved...
View ArticleClik here to view.
Canon buys $40m stake in T2 Biosystems
Canon U.S.A. (NYSE:CAJ) said today it made a $40 million dollar equity investment into diagnostic developer T2 Biosystems Inc. (NSDQ:TTOO), giving Canon a 19.9% stake. Canon said it purchased...
View ArticleClik here to view.
NeuroMetrix launches Quell fybromyalgia pilot study
NeuroMetrix (NSDQ:NURO) said today it is launching a pilot study of its Quell wearable pain relief device for treating patients with fibromyalgia. Waltham, Mass.-based NeuroMetrix said it is partnering...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 22, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Medtronic touts low CD-TLR rates, strong durability in 3-year In.Pact Admiral...
Medtronic (NYSE:MDT) this week released data from 2 clinical studies evaluating its In.Pact Admiral drug-coated balloon for treating claudication and restenosis, touting sustained durability at...
View ArticleClik here to view.
Navidea reels in $1m in Lymphoseek milestone payments
Navidea (NYSE:NAVB) said today it is set to receive $1 million from 2 milestone payments for its Lymphoseek injection designed for lymph nodes detection. The milestone payments come from from its U.S....
View ArticleClik here to view.
Staar Surgical wins Health Canada nod for Visian Toric ICL
Staar Surgical (NSDQ:STAA) said today it won approval from Health Canada’s Medical Devices Bureau for its Evo Visian Toric ICL intraocular lenses. The Evo Visian Toric ICL is designed to be implanted...
View ArticleClik here to view.
ALCOA – The Best Way to Document Your Work
When documenting your research observations, it is important to remember the adage, “If it wasn’t documented, it wasn’t done”. As research professionals, we have an obligation to uphold the highest...
View ArticleClik here to view.
Big Pharma urges acquittal for ex-Acclarent execs
Pharmaceutical giants including Bayer (ETR:BAYN) and Pfizer (NYSE:PFE) filed a motion backing ex-Acclarent executives William Facteau and Patrick Fabian, urging the Massachusetts federal court to...
View ArticleClik here to view.
Draper Labs plans human study of neural implants
Draper Laboratories is reportedly planning for the 1st human study of its neural implants for amputees to begin in late 2016 or early 2017. This follows Phase I findings that demonstrated Draper’s...
View ArticleClik here to view.
Medtronic escapes Infuse lawsuits involving fugitive Ohio doc
Medtronic (NYSE:MDT) yesterday escaped hundreds of lawsuits filed over the allegedly off-label use of its controversial bone-growth product, Infuse, by a Cincinnati doctor who has since fled to...
View Article